Cigna's Evernorth unit is expanding coverage for Neuronetics' therapy for depression to adolescents. Neuronetics announced that Evernorth will offer coverage for its NeuroStar Transcranial Magnetic ...

Structured therapeutic engagement, rather than smartphone deprivation, may be a more effective way to support adolescent well ...

Background: Low back pain (LBP) in adolescents is associated with LBP in later years. In recent years treatments have been administered to adolescents for LBP, but it is not known which physical ...

Neuronetics has secured a groundbreaking green light for its noninvasive transcranial magnetic stimulation technology, saying it is now the first to be cleared by the FDA as an add-on therapy for ...

MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

I specialize in supporting children, adolescents, and young adults navigating anxiety, depression, chronic illness, ADHD, trauma, stress, grief, emotional regulation ...

SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group today announced the launch of two new initiatives across multiple sites exploring the effectiveness of ketogenic therapy for children and adolescents ...

A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney disease and improve health outcomes. The findings could help guide more ...

Adolescent years can be the most challenging with barriers such as anxiety, depression, impulsivity, substance use, and trauma. The family dynamics can suffer out of the lack of cohesion. However, ...

MADISON, Wis., March 24, 2026 /PRNewswire/ -- Inner Haven Wellness, a physician-led provider of specialized eating disorder treatment in Wisconsin, today announced the upcoming launch of its Virtual ...

New data support the use of mavacamten as a treatment option for adolescents with symptomatic obstructive hypertrophic cardiomyopathy, researchers reported at the American College of Cardiology ...